Liraglutide

Product NDC
70377-095
11-digit product format
703770095
Labeler code
70377
Product ID
70377-095_15f41bf3-b403-b32c-e64f-2330120c519e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
liraglutide
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
Biocon Pharma Inc.
Application
ANDA217063
Marketing category
ANDA
Marketing start
2026-03-27
Substance
LIRAGLUTIDE
Active strength
6 mg/mL
Pharmacologic classes
GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217063-001LIRAGLUTIDELIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP22026-02-24

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A217063-001AP2

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A217063-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP22026-02-24caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217063-001LIRAGLUTIDE18MG/3ML (6MG/ML)SOLUTION / SUBCUTANEOUSAP22026-02-24a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A217063-001AP21caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A217063-001AP21a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Liraglutide
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
LIRAGLUTIDE6 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
839I73S42AInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2735350Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0b898330-eca1-f60a-71d2-b91716e336edAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d8dac6c8-0045-42cf-b357-c3350b4ada5cProduct name220251021
0dd952e2-ff48-4739-9b8d-72ae0b326834Product name220200323
ce962b7e-f9f8-43e6-8d30-41514e79f3e4Product name120190201
2f360a13-6ea8-4c2b-b2ef-10133c2836d9Product name120150316

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70377-095-52Liraglutide3 mL in 1 SYRINGE, PLASTICINJECTION, SOLUTION38
70377-095-52Liraglutide3 in 1 CARTONINJECTION, SOLUTION38
70377-095-53Liraglutide3 mL in 1 SYRINGE, PLASTICINJECTION, SOLUTION38
70377-095-53Liraglutide5 in 1 CARTONINJECTION, SOLUTION58

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LiraglutideLIRAGLUTIDEBiocon Pharma Inc.0b898330-eca1-f60a-71d2-b91716e336ed2025-10-16Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 217063
application number: ANDA217063
ndc (product): 70377-095

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2735350liraglutide 6 MG/ML in 3 mL Weight Management Pen InjectorPSN0b898330-eca1-f60a-71d2-b91716e336ed8
2735350Weight Management 3 ML liraglutide 6 MG/ML Pen InjectorSCD0b898330-eca1-f60a-71d2-b91716e336ed8
2735350liraglutide 18 MG per 3 ML Weight Management Pen InjectorSY0b898330-eca1-f60a-71d2-b91716e336ed8

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70377-095-52703770095523 SYRINGE, PLASTIC in 1 CARTON (70377-095-52) / 3 mL in 1 SYRINGE, PLASTIC2026-03-27NoNoCurrent
70377-095-53703770095535 SYRINGE, PLASTIC in 1 CARTON (70377-095-53) / 3 mL in 1 SYRINGE, PLASTIC2026-03-27NoNoCurrent